Related Experiment Video

Updated: Aug 23, 2026

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on: May 17, 2024

[Vascular dementia]

F E de Leeuw1, J van Gijn

  • 1Universitair Medisch Centrum St Radboud, afd. Neurologie, Postbus 9101, 6500 HB Nijmegen. h.deleeuw@neuro.umcn.nl

Nederlands Tijdschrift Voor Geneeskunde
|July 1, 2004
PubMed

Insights

Vascular dementia, common in older adults, is linked to high blood pressure and atherosclerosis. While risk factor management shows promise, its effectiveness in preventing vascular dementia needs clinical trials, and treatments like acetylcholinesterase inhibitors may help slow cognitive decline.

Area of Science:

  • Neurology
  • Geriatrics
  • Epidemiology

Context:

  • Vascular dementia is a prevalent cause of dementia in individuals over 85.
  • Key risk factors include hypertension and atherosclerosis.
  • Diagnosis can be challenging due to silent strokes and overlapping conditions like depression.

Purpose:

  • To summarize the current understanding of vascular dementia.
  • To highlight diagnostic challenges and contributing factors.
  • To review potential therapeutic interventions.

Summary:

  • Vascular dementia affects approximately 5% of those over 85, with hypertension and atherosclerosis as primary risk factors.
  • Onset is typically within three months post-stroke, but silent strokes complicate diagnosis.
  • Population studies suggest managing vascular risk factors reduces incidence, though this lacks randomized trial evidence.

Impact:

  • Highlights the need for randomized clinical trials on vascular dementia prevention.
  • Suggests acetylcholinesterase inhibitors may offer benefits for cognitive decline in vascular dementia patients.
  • Emphasizes the importance of recognizing and managing vascular risk factors to mitigate dementia risk.

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...